IP Library Granted Patent US 11,874,281
Granted Patent B2
US 11,874,281 · App. 17/501,143 · Granted Jan 16, 2024

Assays for detecting modified compounds

Inventors: Elazar Rabbani (New York, NY); Jannis G. Stavrianopoulos (Bay Shore, NY); Joshua Rabbani (New York, NY); Praveen Pande (Holbrook, NY)
Assignee: Enzo Life Sciences, Inc.
G01N33/6803C12Q1/485G01N33/92C12Y207/01091C12Y207/11001G01N2405/08G01N2410/00G01N2440/14G01N2440/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,874,281
App. No.
17/501,143
Granted
Jan 16, 2024
Kind
B2
Abstract

Provided are methods and compositions which are useful for separating, isolating, detecting, and quantifying compounds of interest which have been modified chemically, enzymatically or catalytically from other compounds which have not been so modified. The modifications may take the form of functional groups which are gained, lost or retained by the compounds of interest.

Claims (16)

1. A method for detecting or quantifying an enzyme capable of adding a functional group to a compound in a sample, the method comprising the steps of:

(a) providing:

(i) a compound which can gain a functional group from an enzyme, the compound being directly covalently bound to at least one non-radioactive signaling moiety and the compound comprising sphingosine;

(ii) a sample suspected of containing an enzyme that could add a functional group to the compound; and

(iii) a chemical, enzymatic or catalytic source of the functional group which can be gained by the compound; and

(iv) means to separate the compound which has gained the functional group from the compound which has not gained the functional group;

(b) forming a mixture comprising the compound, the sample and the source of the functional group, and incubating the mixture under conditions suitable for the compound to gain the functional group;

(c) separating and thereby isolating any compound which has gained the functional group from any compound which has not gained the functional group by precipitating said compound which has gained the functional group from the mixture by the addition of a charged metal ion and a solvent selected from the group consisting of ethanol, methanol, isopropyl alcohol, dioxane, and combinations thereof;

(d) resolubilizing said compound which has gained the functional group;

wherein the functional group comprises a phosphate.

2. The method of claim 1 , further comprising detecting or quantifying the non-radioactive signaling moiety in said resolubilized compound having the functional group, to detect or quantify any compound which has gained the functional group.

3. The method of claim 1 , wherein the chemical, enzymatic or catalytic source of the functional group comprises an enzyme and a chemical comprising the functional group.

4. The method of claim 1 , further comprising providing a normalizing reagent to promote precipitation of the compound that has gained the functional group.

5. The method of claim 1 , wherein barium acetate and ethanol are added for precipitation; wherein EDTA is used for resolubilizing the compound and wherein the non-radioactive signaling moiety comprises a fluorescent compound, a phosphorescent compound, a chemiluminescent compound, a chromogenic compound, a chelating compound, an electron dense compound, a magnetic compound, an energy transfer member or pair, an intercalating compound, or any combination thereof.

6. The method of claim 1 , further comprising blocking at least one moiety on the compound that interferes with the compound gaining the functional group in step (b) or separating the compound in step (c).

7. The method of claim 2 , wherein the detecting or quantifying is carried out directly or indirectly.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jul 24, 2023
From: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
To: ENZO BIOCHEM, INC.; ENZO CLINICAL LABS, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP; ENZO LIFE SCIENCES, INC.
Reel/Frame 064369/0031 →
SECURITY INTEREST Recorded Apr 3, 2023
From: ENZO LIFE SCIENCES, INC.; ENZO CLINICAL LABS, INC.; ENZO BIOCHEM, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP
To: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
Reel/Frame 063239/0103 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 27, 2021
From: RABBANI, ELAZAR; RABBANI, JOSHUA; PANDE, PRAVEEN; STAVRIANOPOULOS, JANNIS G.
To: ENZO LIFE SCIENCES, INC.
Reel/Frame 057930/0383 →
Continuity (5)
Continuation 16225669 · Dec 19, 2018
Continuation 15195343 · Jun 28, 2016
Continuation 14296756 · Jun 5, 2014
Division 12806950 · Aug 24, 2010
Related Publication 20220034897A1 · Feb 3, 2022